| Staging in bipolar disorder: from theoretical framework to clinical utility M Berk, R Post, A Ratheesh, E Gliddon, A Singh, E Vieta, AF Carvalho, ... World Psychiatry 16 (3), 236-244, 2017 | 191 | 2017 |
| Adjunctive minocycline treatment for major depressive disorder: a proof of concept trial OM Dean, B Kanchanatawan, M Ashton, M Mohebbi, CH Ng, M Maes, ... Australian & New Zealand Journal of Psychiatry 51 (8), 829-840, 2017 | 99 | 2017 |
| Prebiotics, probiotics, fermented foods and cognitive outcomes: a meta-analysis of randomized controlled trials W Marx, A Scholey, J Firth, NM D’Cunha, M Lane, M Hockey, MM Ashton, ... Neuroscience & Biobehavioral Reviews 118, 472-484, 2020 | 63 | 2020 |
| Protocol and rationale-the efficacy of minocycline as an adjunctive treatment for major depressive disorder: a double blind, randomised, placebo controlled trial OM Dean, M Maes, M Ashton, L Berk, B Kanchanatawan, ... Clinical Psychopharmacology and Neuroscience 12 (3), 180, 2014 | 57 | 2014 |
| Beyond the therapeutic shackles of the monoamines: new mechanisms in bipolar disorder biology J Data-Franco, A Singh, D Popovic, M Ashton, M Berk, E Vieta, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 72, 73-86, 2017 | 43 | 2017 |
| Mitochondrial agents for bipolar disorder C Pereira, V Chavarria, J Vian, MM Ashton, M Berk, W Marx, OM Dean International Journal of Neuropsychopharmacology 21 (6), 550-569, 2018 | 40 | 2018 |
| The therapeutic potential of mangosteen pericarp as an adjunctive therapy for bipolar disorder and schizophrenia MM Ashton, OM Dean, AJ Walker, CC Bortolasci, CH Ng, M Hopwood, ... Frontiers in psychiatry 10, 115, 2019 | 27 | 2019 |
| Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les médicaments à base de … J Sarris, W Marx, MM Ashton, CH Ng, N Galvao-Coelho, Z Ayati, ZJ Zhang, ... The Canadian Journal of Psychiatry 66 (10), 849-862, 2021 | 24 | 2021 |
| Minocycline as adjunctive treatment for major depressive disorder: pooled data from two randomized controlled trials R Zazula, MI Husain, M Mohebbi, AJ Walker, IB Chaudhry, AB Khoso, ... Australian & New Zealand Journal of Psychiatry 55 (8), 784-798, 2021 | 18 | 2021 |
| A systematic review of nutraceuticals for the treatment of bipolar disorder MM Ashton, BE Kavanagh, W Marx, M Berk, J Sarris, CH Ng, M Hopwood, ... The Canadian Journal of Psychiatry 66 (3), 262-273, 2021 | 15 | 2021 |
| Diet quality, dietary inflammatory index and body mass index as predictors of response to adjunctive N-acetylcysteine and mitochondrial agents in adults with … MM Ashton, OM Dean, W Marx, M Mohebbi, M Berk, GS Malhi, CH Ng, ... Australian & New Zealand Journal of Psychiatry 54 (2), 159-172, 2020 | 14 | 2020 |
| Patterns of pharmacotherapy for bipolar disorder: a GBC survey B Singh, AK Yocum, R Strawbridge, KE Burdick, CE Millett, AT Peters, ... Bipolar disorders 26 (1), 22-32, 2024 | 12 | 2024 |
| Role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disorders: a protocol for a systematic review and meta-analysis BE Kavanagh, SL Brennan-Olsen, A Turner, OM Dean, M Berk, ... BMJ open 9 (4), e025145, 2019 | 12 | 2019 |
| Personality disorder and functioning in major depressive disorder: a nested study within a randomized controlled trial BE Kavanagh, LJ Williams, M Berk, A Turner, HJ Jackson, M Mohebbi, ... Brazilian Journal of Psychiatry 42, 14-21, 2019 | 11 | 2019 |
| Physical activity as a predictor of clinical trial outcomes in bipolar depression: a subanalysis of a mitochondrial-enhancing nutraceutical randomized controlled trial MM Ashton, M Mohebbi, A Turner, W Marx, M Berk, GS Malhi, CH Ng, ... The Canadian Journal of Psychiatry 65 (5), 306-318, 2020 | 10 | 2020 |
| Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial MM Ashton, M Berk, CH Ng, M Hopwood, S Dodd, A Turner, E Brown, ... Brazilian Journal of Psychiatry 41, 245-253, 2018 | 10 | 2018 |
| Systematic review and meta-analysis of the role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disorders BE Kavanagh, MM Ashton, SP Cowdery, OM Dean, A Turner, M Berk, ... Journal of Affective Disorders 279, 711-721, 2021 | 9 | 2021 |
| Coping with COVID-19: Exploring coping strategies, distress, and post-traumatic growth during the COVID-19 pandemic in Australia BE Kavanagh, JS O’Donohue, MM Ashton, M Lotfaliany, M McCallum, ... Frontiers in psychiatry 13, 1025767, 2022 | 8 | 2022 |
| Protocol and Rationale: A 24-week double-blind, randomized, placebo controlled trial of the efficacy of adjunctive Garcinia mangostana Linn.(mangosteen) pericarp for schizophrenia A Turner, JJ McGrath, OM Dean, S Dodd, A Baker, SM Cotton, JG Scott, ... Clinical Psychopharmacology and Neuroscience 17 (2), 297, 2019 | 8 | 2019 |
| Exploring interleukin-6, lipopolysaccharide-binding protein and brain-derived neurotrophic factor following 12 weeks of adjunctive minocycline treatment for depression K Hasebe, M Mohebbi, L Gray, AJ Walker, CC Bortolasci, A Turner, ... Acta neuropsychiatrica 34 (4), 220-227, 2022 | 7 | 2022 |
